Results 31 to 40 of about 757 (98)
Hiding in Plain Sight: Inflammation in Iatrogenic Cerebral Amyloid Angiopathy. [PDF]
Banerjee G, Werring DJ.
europepmc +3 more sources
Iatrogenic cerebral amyloid angiopathy after red blood cell transfusion? [PDF]
DiFrancesco JC +6 more
europepmc +3 more sources
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ) transmission in humans (in 2015) and subsequent experimental confirmation (in 2018), clinical cases of iatrogenic cerebral amyloid angiopathy (CAA)—attributed to the transmission of Aβ seeds—have been increasingly recognised and reported.
Gargi Banerjee +15 more
openaire +3 more sources
Iatrogenic Cerebral Amyloid Angiopathy after Cadaveric Dura Mater Transplantation to an Intact Brain Surface: A Case Report [PDF]
Tsuyoshi Hamaguchi
exaly +2 more sources
Cerebral amyloid angiopathy (CAA) is a small vessel disease, causing spontaneous intracerebral hemorrhage (ICH) in the elderly. It is strongly associated with Alzheimer disease (AD), as most CAA patients show deposition of Aβ—i.e.
Riccardo Milani +11 more
doaj +1 more source
Little is known about the effects of parenchymal or vascular amyloid β peptide (Aβ) deposition in the brain. We hypothesized that Aβ strain-specific information defines whether Aβ deposits on the brain parenchyma or blood vessels.
Tsuyoshi Hamaguchi +7 more
doaj +1 more source
Amyloid-β (Aβ) pathology transmission has been described in patients following iatrogenic exposure to compounds contaminated with Aβ proteins. It can induce cerebral Aβ angiopathy resulting in brain hemorrhages and devastating clinical impacts ...
Suzanne Lam +11 more
doaj +1 more source
3147 When the answer is hiding in the medical records: iatrogenic cerebral amyloid angiopathy
Rohit Sharma +2 more
doaj +2 more sources
Amyloid-β Seeds in Alzheimer's Disease: Research Challenges and Implications. [PDF]
The amyloid cascade hypothesis places amyloid‐β (Aβ) at the center of Alzheimer's disease (AD) pathogenesis. Evidence suggests that AD progresses in two phases: an early phase driven by Aβ aggregation and a later phase that progresses at least partly independently of Aβ.
Beschorner N +3 more
europepmc +2 more sources
IATROGENIC AMYLOID ANGIOPATHY AS A NEW CLINICAL PHENOMENON
Background. A literature search of various databases revealed mixed and largely contradictory results regarding the etiology, pathogenesis, prevalence, and diagnostic criteria of cerebral amyloid angiopathies and iatrogenic amyloid angiopathies, which ...
Ivan A. Stepanov +2 more
doaj +1 more source

